1469P Efficacy and safety of pembrolizumab/axitinib combination in metastatic renal cell carcinoma (mRCC): A multicentric prospective analysis (ProPAXI study)
Autor: | Guida, A., Maruzzo, M., Lai, E., Bimbatti, D., Pierantoni, F., Dionese, M., Caserta, C., Mosillo, C., Calandrella, M.L., Macrini, S., Fornarini, G., Zanardi, E., Damassi, A., Calabrò, F., Cerbone, L., Astore, S., Galli, L., Bracarda, S. |
---|---|
Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S1218-S1218 |
Databáze: | ScienceDirect |
Externí odkaz: |